Home  |  Careers  |  Contact Us
Spartan RX CYP2C19 System. Sample to result. DNA on demand.
FDA-Cleared For In Vitro Diagnostic Use
CYP2C19 testing. 100% Sensitivity. 100% Specificity. Accurate and reliable.

A third-party study of 325 individuals found that the Spartan RX CYP2C19 System was 100% sensitive and 100% specific compared to bi-directional DNA sequencing.
Learn more ›

Rapid CYP2C19 testing genetic results. 1 in 3 people carry mutations.

Carrying a CYP2C19 mutation can impair drug metabolism. 15% of all prescribed drugs are metabolized by CYP2C19 enzymes, including anti-platelet drugs, anti-depressants and proton pump inhibitors.
Learn more ›

Simple and automated. CYP2C19 testing results print in an hour.

Printer included with system. User receives a results printout after the run is complete. No user intervention or analysis required.
Watch demo ›

No CYP2C19 testing sample preparation. Test up and running in seconds.

No pipetting. No DNA extraction. No complicated procedures. Just swab the patient's cheek and insert the sample into the tube.
Watch demo ›

Intuitive interface. Designed for ease use.

Just scan the test kit barcodes and enter in the patient information. Press go and walk away. Barcode scanner included.
Watch demo ›

Small footprint. Saves benchtop space.

Compact and lightweight. About the size of a shoebox. Easily fits into your existing workspace.
Learn more ›

Landmark clinical trial with Mayo Clinic.

6,000-patient clinical trial entitled "Tailored Antiplatelet Initiation to Lessen Outcomes due to Clopidogrel Resistance after Percutaneous Coronary Interventions" (TAILOR PCI).
Learn more ›

Medicare CYP2C19 test reimbursement. CPT Code 81225.

Reimbursement available for Medicare and most insurers. CYP2C19 gene analysis of common variants for drug metabolism.